Test Bank - Pharmacology: A Patient-Centered Nursing

Process Approach (9th Edition,) PHARMACOLOGY

9TH EDITION MCCUISTION TEST BANK

 1 / 4

Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,

2017)

PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

Table of Contents

Table of Contents

Chapter 01: Drug Development and

Ethical Considerations

Chapter 02: Pharmacokinetics,

Pharmacodynamics, and

Pharmacogenetics

Chapter 03: Cultural Considerations

Chapter 04: Complementary and

Alternative Therapies

Chapter 05: Pediatric Considerations

Chapter 06: Geriatric Considerations

Chapter 07: Drugs in Substance Use

Disorder

Chapter 08: The Nursing Process and

Patient-Centered Care

Chapter 09: Safety and Quality

Chapter 10: Drug Administration

Chapter 11: Drug Calculations

Chapter 12: Fluid Volume and

Electrolytes

Chapter 13: Vitamin and Mineral

Replacement

Chapter 14: Nutritional Support

Chapter 15: Adrenergic Agonists and

Antagonists

Chapter 16: Cholinergic Agonists and

Antagonists

Chapter 17: Stimulants

Chapter 18: Depressants

Chapter 19: Antiseizure Drugs

Chapter 20: Drugs for Parkinsonism and

Alzheimer's Disease

Chapter 21: Drugs for Neuromuscular

Disorders and Muscle Spasms

Chapter 22: Antipsychotics and

Anxiolytics

Chapter 23: Antidepressants and Mood

Stabilizers

Chapter 24: Antiinflammatories

Chapter 25: Analgesics

Chapter 26: Antibacterials

Chapter 27: Antituberculars, Antifungals,

and Antivirals

Chapter 28: Peptides, Antimalarial, and

Anthelmintic

Chapter 29: HIV- and AIDS-Related

Drugs

Chapter 30: Transplant Drugs

Chapter 31: Vaccines

Chapter 32: Anticancer Drugs

Chapter 33: Targeted Therapies to Treat

Cancer

Chapter 34: Biologic Response

Modifiers

Chapter 35: Upper Respiratory

Disorders

Chapter 36: Lower Respiratory

Disorders

Chapter 37: Cardiac Glycosides,

Antianginals, and Antidysrhythmics

Chapter 38: Diuretics

Chapter 39: Antihypertensive

Chapter 40: Anticoagulants,

Antiplatelets, and Thrombolytics

Chapter 41: Antihyperlipidemics and

Peripheral Vasodilators

Chapter 42: Gastrointestinal Tract

Disorders

Chapter 43: Antiulcer Drugs

Chapter 44: Eye and Ear Disorders

Chapter 45: Dermatologic Disorders

Chapter 46: Pituitary, Thyroid,

Parathyroid, and Adrenal Disorders

Chapter 47: Antidiabetics

Chapter 48: Urinary Disorders

Chapter 49: Pregnancy and Preterm

Labor

Chapter 50: Labor, Delivery, and

Postpartum

Chapter 51: Neonatal and Newborn

Chapter 52: Women's Reproductive

Health

Chapter 53: Men's Reproductive Health

Chapter 54: Sexually Transmitted

Infections

Chapter 55: Adult and Pediatric

Emergency Drugs

 2 / 4

Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,

2017)

PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

Chapter 01: Drug Development and Ethical Considerations

MULTIPLE CHOICE

1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of

the contents of a Single-use vial. Which nursing action is correct?

a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.

b. Keep the remaining amount in the patient’s drawer to give at the next dose.

c. Record the amount unused in the patient’s medication record.

d. Dispose of the vial with the remaining drug into a locked collection box.

ANS: A

Schedule II drugs are controlled substances, and all must be accounted for. When wasting a

portion of a drug, another nurse should observe and cosign that a drug was wasted.

DIF: COGNITIVE LEVEL: Applying (Application)

TOP: NURSING PROCESS: Nursing Intervention

MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic

form. The nurse understands that a generic medication will have a name that

a. is a registered trademark.

b. is always capitalized.

c. describes the drugs chemical structure.

d. is non-proprietary.

ANS: D

The generic name is the official, non-proprietary name for a drug. The brand name is the

trademark name and is always capitalized. The chemical name describes the chemical structure

of the drug.

DIF: COGNITIVE LEVEL: Understanding (Comprehension)

TOP: NURSING PROCESS: N/A

MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

3. A patient receives a prescription on which the provider has noted that a generic

medicationmay be given.The patient asks the nurse what this means. What will the nurse tell

the patientabout generic drugs?

a. They contain the same inert ingredients as brand-name drugs.

b. They have chemical structures that are identical to proprietary drugs.

c. They tend to be less expensive than brand-name drugs.

d. They undergo extensive testing before they are marketed.

ANS: C

Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brandname drug. They tend to be less expensive because manufacturers of these drugs do not have

to do the extensive testing required of brand-name drugs before marketing. They are not

identical to brand-name drugs and often have different inert ingredients.

DIF: COGNITIVE LEVEL: Applying (Application)

TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching

MSC: NCLEX: Management of Client Care

4. The nurse reviews information about a drug and notes the initials USP after the drugs official

name. The nurse understands that this designation indicates the drug

a. is a controlled substance.

 3 / 4

Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition,

2017)

PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK

b. is approved by the U.S. Food and Drug Administration (FDA).

c. is available in generic form.

d. meets quality and safety standards.

ANS: D

The USP designation is given to drugs that have met high standards for therapeutic use, patient

safety, quality, purity, strength, packaging safety, and dosage form by the United States

Pharmacopoeia National Formulary. The FDA classifies controlled substances with Roman

numerals from I to V. The USP designation does not indicate FDA approval. The USP

designation does not indicate generic availability.

DIF: COGNITIVE LEVEL: Understanding (Comprehension)

TOP: NURSING PROCESS: N/A

MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

5. The nurse is preparing to give a medication to a child. The child’s parent asks whether the

drug is safe for children. How will the nurse respond to the parent?

a. Drugs are tested on adults and safe doses for children are based on weights compared to

adult weights.

b. Drugs are deemed safe for children over time when repeated use proves effectiveness and

safety.

c. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric

use.

d. Drugs are tested on children in post marketing studies and on a limited basis.

ANS: C

The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.

DIF: COGNITIVE LEVEL: Applying (Application)

TOP: NURSING PROCESS: Nursing Intervention

MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

6. Which law(s) govern all drug administration by nurses?

a. Drug Regulation and Reform Act

b. FDA Amendments Act

c. Nurse Practice Acts

d. The Controlled Substances Act

ANS: C

Each states Nurse Practice Act identifies how nurses administer medications. The other acts

govern how drugs are marketed and tested.

DIF: COGNITIVE LEVEL: Understanding (Comprehension)

TOP: NURSING PROCESS: N/A

MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

7. The nurse administers a drug and miscalculates the dose by placing the decimal place one

space to the right, resulting in a 10-fold overdose and the death of the patient. What offense

does this represent?

a. Malfeasance

b. Malpractice

c. Misfeasance

d. Nonfeasance

ANS: C

Misfeasance is negligence in giving either the wrong drug or the wrong dose, resulting in the

death of the patient.

Powered by qwivy(www.qwivy.org)

 4 / 4